Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.055 USD | +2.22% |
|
-13.38% | +184.38% |
06-24 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to S&P TMI Index | CI |
06-10 | Skye Bioscience, Inc. Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program | CI |
- Stock Market
- Equities
- EMBI Stock
- News Skye Bioscience, Inc.
- Trading Ideas